UNSPSC 51343507: Cidofovir sodium

This classification denotes an antiviral agent with the molecular formula C8H12N3O6P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M83JB37U61, chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, disodium salt, (s)-, but more generally known as cidofovir sodium, which bears US NIH Compound Identifier 135406. European Medicines Agency schedules cidofovir sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06257MIG.

Most nations, for tariff purposes, schedule cidofovir sodium under HS 29335995. SMILES: C1CN(C(=O)NC1N)C[C@@H](CO)OCP(=O)([O-])[O-].[NA+].[NA+].

UNSPSC 51343507 Cidofovir sodium is a Commodity code that nominally designates a specific antiviral pharmaceutical, but recent state and local procurement activity under this code shows minimal direct alignment with that product. The most recent opportunities tagged to this code involve broader pharmaceutical and medical supply procurement — generic drugs, over-the-counter products, naloxone, emergency medical supplies, and direct-to-manufacturer prescription programs — rather than cidofovir specifically. State and local buyers using this code span health departments, county health systems, fire rescue divisions, and multistate cooperative purchasing alliances. The work solicited includes competitive bidding for emergency medical and first aid supplies, cooperative purchasing for pharmaceutical distribution through authorized wholesalers, and exploratory market research on direct-to-manufacturer prescription models.

Recent activity appears concentrated in Florida, Texas, and Minnesota. The City of Tampa Fire Department Rescue Division issued IFB 26P00145 in March 2026 (due Mar 13, 2026) for 169 line items of medical and first aid supplies with an estimated contract value of $700,000 and a designated small local business enterprise set-aside with a 5 percent bid discount. Seminole County, Florida posted IFB 60459723LAS in June 2026 (due Jul 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP in January 2026 (due Mar 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities. The Texas Health and Human Services Commission posted an RFI in April 2026 exploring vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program. The code shows sporadic use and mismatch between its nominal scope and the actual work being bought; practitioners should verify issuing-body coding before pursuing opportunities under this category.